Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists

Elsevier

Available online 23 July 2025

Diagnostic and Interventional ImagingAuthor links open overlay panel, Section snippetsHuman rights

Not applicable for editorials.

Informed consent and patient details

Not applicable for editorials.

Authors contribution

All authors attest that they meet the current International Committee of Medical Journal Editors (ICMJE) criteria for authorship.

Funding

This editorial received no specific funding.

Declaration of competing interest

The authors have no competing interest to declare in relation with this editorial.

References (8)

There are more references available in the full text version of this article.

View full text

© 2025 Société française de radiologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Comments (0)

No login
gif